Integrated Pathway-Based Approach Identifies Association between Genomic Regions at CTCF and CACNB2 and Schizophrenia
Dilafruz Juraeva(Merck KGaA, Darmstadt (Germany)), Benedikt Brors(German Cancer Research Center), Britta Haenisch(Federal Institute for Drugs and Medical Devices), Roel A. Ophoff(University of California, Los Angeles), Anders D. Børglum(Aarhus University), Thomas W. Mühleisen(University of Bonn), Ina Giegling(Ludwig-Maximilians-Universität München), Stephan Ripke(Broad Institute), Dan Rujescu(Martin Luther University Halle-Wittenberg), Thomas G. Schulze(Universität Hamburg), Stephanie H. Witt(Heidelberg University), Marc Zapatka(German Cancer Research Center), Igor Nenadić(Philipps University of Marburg), Franziska Degenhardt(University of Duisburg-Essen), Jana Strohmaier(Heidelberg University), Heinrich Sauer(Justus-Liebig-Universität Gießen), Jens Treutlein(Heidelberg University), Marcella Rietschel(Heidelberg University), Markus M. Nöthen(University of Bonn), Manuel Mattheisen(Aarhus University), Sandra Meier(Heidelberg University), Sven Cichon(University of Bonn), Markus Leber(University of Bonn), Wolfgang Maier(Boston University), Christoph Lange(Harvard University), Rainald Mößner(University of Würzburg), Josef Frank(Heidelberg University)
Cited by 61
Related Papers
Biological insights from 108 schizophrenia-associated genetic loci
|Nature|2014|8.1k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k